Effect of Medium Components on the Lipstatin Production by Streptomyces toxytricini
![]() |
Lim, Mi-Ok
(Faculty of Pharmacy, Yeungnam University)
Yin, Wencui (Faculty of Pharmacy, Yeungnam University) Lee, Ji-Seon (Faculty of Pharmacy, Yeungnam University) Yu, Yeon-Su (Faculty of Biotechnology, Yeungnam University) Kim, Sang-Dal (Faculty of Biotechnology, Yeungnam University) Nam, Doo-Hyun (Faculty of Pharmacy, Yeungnam University) |
1 | 남두현. 1992. 방선균을 이용한 항생물질 발효. 미생물과 산업 18, 63-68 |
2 | Aharonowitz, Y. 1980. Nitrogen metabolite regulation of antibiotic biosynthesis. Ann. Rev. Microbiol. 34, 209-233 DOI ScienceOn |
3 | Demain, A.L., Y.M. Kennel, and Y. Aharonowitz. 1979. Carbon catabolite regulation of secondary metabusm, p.163-185. In A.T. Bull, D.C. Ellwood, and C. Ratledge (ed.) Microbial technology: current state, future prospects. Cambridge University Press, Cambridge |
4 | Imanaka, T., Y. Moriyama, G.G. Ecsedi, T. Aoyagi, K. Amanumamoto, S. Ohkuma, and T. Takano. 1983. Esterastin: A potent inhibitor of lysosomal acid lipase. J. Biochem. 94, 1017-1020 DOI |
5 | Eisenreich, W., E. Kupfer, W. Weber, and A. Bacher. 1997. Tracer studies with crude U-13C-lipid mixtures. Biosynthesis of the lipase inhibitor lipstatin. J. Biol. Chem. 272, 867-874 DOI ScienceOn |
6 | Weibel, E.K., P. Hadvary, E. Hochuli, E. Kupfer, and H. Lengsfeld. 1987. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J. Antibiot. 40, 1081-1085 DOI |
7 | Zhi, J., A.T. Melia, C. Funk, A. Viger-Chougnet, G. Hopfgartner, and B. Lausecker. 1996. Metabolic profiles of minimally absorbed orlistat in obese/overweight volunteers. J. Clin. Pharmacol. 36, 1006-1011 DOI ScienceOn |
8 | Hochuli, E., E. Kupfer, R. Maurer, W. Meister, Y. Mercadal, and K. Schmidt. 1987. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxitricini. II. Chemistry and structure elucidation. J. Antibiot. 40, 1086-1091 DOI |
9 | Hollander, P.A., S.C. Elbein, I.B. Hirsch, D. Kelley, J. McGill, T. Taylor, S.R. Weiss, S.E. Crockett, R.A. Kaplan, J. Comstock, C.P. Lucas, P.A. Lodewick, W. Canovatchel, J. Chung, and I. Hauptman. 1998. Role of orlistat in the treatment of obese patients with type 2 diabetes. Diabetes Care 21, 1288-1294 DOI ScienceOn |
10 | Goese, M., W. Eisenreich, E. Kupfer, W. Weber, and A. Bacher. 2000. Biosynthetic origin of hydrogen atoms in the lipase inhibitor lipstatin. J. Biol. Chem. 275, 21192-21196 DOI ScienceOn |
11 | Martin, J.F. and A.L. Demain 1980. Control of antibiotic biosynthesis. Microbiol. Rev. 44, 230-251 |
12 | Imanaka, T., K. Moto, S. Ohkuma, and T. Takano. 1981. Purification and properties of rabbit liver acid lipase (4-methylumbelliferyl oleate hydrolase). Biochim. Biophys. Acta. 665, 322-330 DOI ScienceOn |
![]() |